Exhibit 16.1
|
March 25, 2021
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K dated March 25, 2021 of Pluristem Therapeutics Inc. and are in agreement with the statements contained in the second, third and fourth of Item 4.01. We have no basis to agree or disagree with other statements of the registrant contained therein.
/s/ Kost Forer Gabbay & Kasierer | ||
Tel Aviv, Israel March 25, 2021 | Kost Forer Gabbay & Kasierer A Member of Ernst & Young Global |